Understanding CLL

ASH CLL News 2018: Tools for Staying Up-to-Date on Research

At the recent 2018 American Society of Hematology (ASH) conference in San Diego, Patient Power host and CLL patient advocate, Lee Swanson interviews Dr. Anthony Mato to review key research developments.

Published:

When Should CLL Patients Consider Treatment for Fatigue?

A Patient Power community member who struggles with fatigue wants to know more about indications for treatment. Can the side effect be attributable to other health issues? Tune in to hear Dr. Jeff Sharman’s expert perspective on treating CLL patients with fatigue.

Published:

ASH 2018 Annual Meeting: A Patient Perspective on CLL Treatment Developments

From the 2018 American Society of Hematology (ASH) annual meeting in San Diego, CA, CLL patient Lee Swanson joins Patient Power to discuss the impact of research, education and finding a specialist on a person’s cancer care. Tune in to find out more about ASH 2018 from a patient’s perspective.

Published:

ASH CLL News 2018: How Could Research Results Impact You?

At the 2018 American Society of Hematology (ASH) conference in San Diego, Patient Power host and CLL patient advocate, Lee Swanson, is joined by Dr. Kerry Rogers, from The Ohio State University Medical Center.

Published:

Understanding the Ins and Outs of Watch and Wait

Many CLL patients wonder why, after being diagnosed with cancer, they aren’t being treated immediately. How can patients be proactive during watch and wait? How long does the watch and wait period last? Watch the full-length replay now to learn more from an expert panel.

Published:

Setting CLL Treatment Goals and Determining a Plan That’s Right for You

Can a patient’s CLL genetics indicate which therapy will be most effective? Tune in to hear Dr. Philip Thompson review the goals of CLL care, prognostic factors that influence treatment and which patient subset novel agents will benefit.

Published:

CLL ASH News 2018: Staying Informed About Clinical Trials

At the 2018 American Society of Hematology (ASH) conference in San Diego, Patient Power host and CLL patient advocate, Lee Swanson, interviews Dr. Adrian Wiestner, Senior Investigator, Laboratory of Lymphoid Malignancies at the National Heart, Lung, and Blood Institute (NHLBI).

Published:

CLL Prognosis: What Can Genetic Testing Reveal About Progression?

What diagnostic testing is important for CLL patients? How do genetic mutations impact prognosis, disease behavior and treatment decisions? Watch now to hear recommendations from a panel of experts.

Published:

ASH 2018 Daily Wrap: CLL News

On location in San Diego, CA, Patient Power founders Andrew and Esther Schorr are joined by a panel of experts to discuss research developments announced at ASH 2018. Watch day three of Patient Power’s daily wrap to hear the latest blood cancer-related treatment news.

Published:

Showing 9 of 275 programs
Advertisement
Join Our Community Register for Events Read Our Latest Blog
Advertisement

Page last updated on February 28, 2018